Project Grant R01AG085561
Award Date
9/30/24
Completion Date
5/31/29
Dollars Obligated
$1.2M
Federal Agency
National Institute on Aging
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $497,878 to Einsenca Inc. to conduct a first-in-human Phase 0 clinical study of the 18F-EH301 PET imaging agent. The goal is to assess the agent's ability to cross the human blood-brain barrier and validate its activation by myeloperoxidase (MPO) in the brains of patients with early-stage Alzheimer's disease. The award period runs from July 1, 2025 to June 30, 2026. This research aims to develop...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $815,215 to Yale University to conduct a multimodal imaging study examining sex-based contributors to vulnerability to Alzheimer's disease (AD). The study aims to leverage a new prospective cohort and open-source datasets to understand the impact of sex and sex-based factors, such as reproductive period and APOE genotype, on functional brain networks and the progression of tau pathology in...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $106,464 to Brandeis University to conduct research on the associations between monoamine neurotransmitter systems, tau pathology, and emotional memory in aging. The research will utilize positron emission tomography (PET) imaging techniques to measure monoamine synthesis capacity and tau pathology in the brain, and relate these measures to performance on an emotional memory task. The findings...
The National Institute on Aging (NIA) awarded a $137,895 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the University of California, Berkeley (UC Berkeley) with a project period from December 3, 2024 to July 31, 2027. The grant will fund a study to investigate how brain network connectivity is associated with Alzheimer's disease (AD) risk, longitudinal pathology accumulation, and aging. Specifically, the project will use positron emission tomography (PET)...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $426,250 to Wake Forest University Health Sciences to develop and evaluate a novel positron emission tomography (PET) radiotracer, [11C]TM-N1324, to measure levels of the G-protein coupled receptor GPR39 in rodent models and postmortem human brain tissues of Alzheimer's disease (AD). The project aims to establish the utility of this PET imaging approach for quantifying GPR39, which is implicated...
The National Institute on Aging (NIA) awarded a $427,915 Project Grant (CFDA 93.866 - Aging Research) to the University of Missouri System to develop fluorine-18 (F-18) positron emission tomography (PET) radiotracers targeting alpha-2C adrenergic receptors (2C-ARs) and evaluate their preclinical properties. The project aims to design and synthesize 1,4-benzodioxane derivatives based on the existing 2C-AR radiotracer [11C]ORM13070, with the goal of creating improved F-18 radiotracers for...
This $107,948 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to enhance understanding of the biological signatures that distinguish subgroups of patients with Alzheimer's disease (AD). The key goals are to: Determine if AD subtypes can be identified solely using magnetic resonance imaging (MRI)-derived features through the application of machine learning algorithms. Integrate epigenetic profiles, including small non-coding RNA expression and DNA...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $461,146 to Yale University to conduct research on the dysregulation of cortical astrocytes in models of Alzheimer's disease. The research aims to: Assess the early loss of state-dependent spatiotemporal dynamics of astrocytic signaling as an initial consequence of Alzheimer's pathology. Investigate the progressive loss of coupling between noradrenergic signaling and astrocyte activity due...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Yale University totals $460,548 and runs from September 30, 2024 to August 31, 2026. The project aims to develop neuroimaging methodologies for the early detection of Alzheimer's disease (AD) by examining olfactory and memory function in a transgenic rat model. Key activities include: Longitudinal imaging and behavioral studies on transgenic AD and wild-type rats from early to advanced disease...
This Project Grant award of $372,690 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to discover the heterogeneous causal pathophysiology of Alzheimer's disease (AD). The project will develop new statistical methods to uncover how amyloid-beta, tau accumulation, and cognition are causally related in different AD subpopulations. The goal is to reveal optimal treatment windows and target groups for therapies that reduce amyloid-beta or...